Panel Discussion – Improving the Understanding of IBD Patient Subtype to Permit Bespoke Treatment Options

Time: 9:30 am
day: Conference Day One

Details:

  • What procedure can we implement to successfully standardize and identify novel biomarkers that are associated with specific patient subtypes?
  • How can we develop companion diagnostics that align with the unique characteristics of each patient subtype to personalize their IBD treatment journey?
  • Assessing how patient subtype understanding can permit increased drug response rate
  • Exploring the potential for patient subtype-driven drug development to enhance treatment outcomes and reduce adverse effects

Speakers: